A transcriptional cofactor GRIP1 drives PPARγ DNA binding and p300-dependent enhancer activity during homeostatic macrophage polarization
Science Advances · 2026
DOI: 10.1126/sciadv.aeh4524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Marija Dacic und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Special Surgery Research Institute, The David Rosensweig Genomics Center, New York, NY, USA. Hauptthemen laut MEDLINE: PPAR gamma, Macrophages, Nerve Tissue Proteins, Enhancer Elements, Genetic. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Homeostatic macrophages maintain tissue health and resolve inflammation. Upon sustained exposure to type II cytokine IL4, transcription factors STAT6, KLF4, EGR2 and a ligand-regulated nuclear receptor PPARγ orchestrate the M2 IL4 ‘polarization’, marked by enhancer RNA (eRNA) production near multiple M2 genes. The mechanisms of enhancer activation by unliganded PPARγ are poorly understood. We interrogated cofactor requirements for PPARγ-driven gene expression in M2 IL4 , including those lacking PPARγ or a ligand-dependent nuclear receptor coregulator NCoA2/GRIP1 vs. macrophages treated with the PPARγ agonist rosiglitazone. As expected, rosiglitazone activated conventional PPARγ targets; GRIP1 deletion blunted their induction and depleted GRIP1-interacting histone acetyltransferase p300 from PPARγ-bound sites. Surprisingly, GRIP1 colocalized with unliganded PPARγ in M0 and M2 IL4 , and GRIP1 ablation dramatically reduced genome-wide DNA binding of PPARγ itself while promoting broad deposition of CTCF insulator. Functionally, GRIP1 deletion mirrored PPARγ deficiency, establishing GRIP1 as a central regulator of unliganded PPARγ DNA binding, required for both eRNA and mRNA transcription of PPARγ targets in homeostatic macrophages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hospital for Special Surgery Research Institute, The David Rosensweig Genomics Center, New York, NY, USA.
- Graduate Program in Physiology, Biophysics and Systems Biology, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
- Graduate Program in Immunology and Microbial Pathogenesis, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
- Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA.
ORCID-Profile: Marija Dacic, William J Stein, Ruoxi Yuan, Dinesh K Deochand, Joshua K Morrison, Ketsia Seide, Yurii Chinenov, Inez Rogatsky
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- The Hospital for Special Surgery David Rosensweig Genomics Center
Zitieren
APA
Dacic, M., Stein, W. J., Yuan, R., Deochand, D. K., Morrison, J. K., Seide, K., Chinenov, Y., & Rogatsky, I. (2026). A transcriptional cofactor GRIP1 drives PPARγ DNA binding and p300-dependent enhancer activity during homeostatic macrophage polarization. Science Advances. https://doi.org/10.1126/sciadv.aeh4524
Vancouver
Dacic M, Stein WJ, Yuan R, Deochand DK, Morrison JK, Seide K, et al. A transcriptional cofactor GRIP1 drives PPARγ DNA binding and p300-dependent enhancer activity during homeostatic macrophage polarization. Science Advances. 2026. doi:10.1126/sciadv.aeh4524
BibTeX
@article{Dacic2026,
author = {Dacic, Marija and Stein, William J and Yuan, Ruoxi and Deochand, Dinesh K and Morrison, Joshua K and Seide, Ketsia and Chinenov, Yurii and Rogatsky, Inez},
title = {A transcriptional cofactor GRIP1 drives PPARγ DNA binding and p300-dependent enhancer activity during homeostatic macrophage polarization},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aeh4524}
}
EUVIMED